Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 755,859 | 709,171 | 689,892 | 652,800 | 580,656 |
| Receivables | 130,834 | 126,477 | 106,409 | 65,863 | 71,265 |
| Inventories | 34,930 | 37,166 | 28,029 | 18,650 | 19,778 |
| TOTAL | $940,390 | $894,030 | $852,453 | $758,739 | $685,718 |
| Non-Current Assets | |||||
| PPE Net | 994 | 1,037 | 1,077 | 1,149 | 1,239 |
| Investments And Advances | 27,286 | 22,536 | 19,167 | 21,256 | 24,208 |
| Intangibles | 121,971 | 131,674 | 128,639 | 137,983 | 147,327 |
| Other Non-Current Assets | 56,969 | 54,702 | 50,266 | 52,788 | 50,380 |
| TOTAL | $207,220 | $209,949 | $199,149 | $213,176 | $223,154 |
| Total Assets | $1,147,610 | $1,103,979 | $1,051,602 | $971,915 | $908,872 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,151 | 11,202 | 9,096 | 5,528 | 11,197 |
| Accrued Expenses | 125,247 | 135,950 | 119,639 | 107,479 | 100,452 |
| TOTAL | $132,398 | $147,152 | $128,735 | $113,007 | $111,649 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,515 | 2,559 | 2,622 | 2,881 | 2,940 |
| TOTAL | $2,515 | $2,559 | $2,622 | $2,881 | $2,940 |
| Total Liabilities | $134,913 | $149,711 | $131,357 | $115,888 | $114,589 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 122,381 | 122,124 | 122,912 | 122,391 | 121,975 |
| Common Shares | 122 | 123 | 123 | 122 | 122 |
| Retained earnings | 523,349 | 474,188 | 446,789 | 394,006 | 341,898 |
| Other shareholders' equity | 8 | 0 | 0 | 31 | -17 |
| TOTAL | $1,012,697 | $954,268 | $920,245 | $856,027 | $794,283 |
| Total Liabilities And Equity | $1,147,610 | $1,103,979 | $1,051,602 | $971,915 | $908,872 |